These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38360294)

  • 21. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perioperative and Survival Outcomes of Patients Treated With Robot-Assisted Partial Nephrectomy and Percutaneous Microwave Ablation for Small Renal Masses: A Single Center Experience.
    Lucignani G; De Lorenzis E; Ierardi AM; Silvani C; Marmiroli A; Nizzardo M; Albo G; Carrafiello G; Montanari E; Boeri L
    Clin Genitourin Cancer; 2024 Apr; 22(2):237-243. PubMed ID: 38065718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microwave versus cryoablation and radiofrequency ablation for small renal mass: a multicenter comparative analysis.
    Pandolfo SD; Carbonara U; Beksac AT; Derweesh I; Celia A; Schiavina R; Elbich J; Basile G; Hampton LJ; Cerrato C; Costa G; Bianchi L; Lucarelli G; Mirone V; Imbimbo C; Kim FJ; Del Giudice F; Capitanio U; Kaouk J; Autorino R
    Minerva Urol Nephrol; 2023 Feb; 75(1):66-72. PubMed ID: 36286402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
    Zhou W; Arellano RS
    J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients.
    Schmit GD; Atwell TD; Callstrom MR; Farrell MA; Leibovich BC; Patterson DE; Chow GK; Blute ML; Charboneau JW
    J Endourol; 2010 Aug; 24(8):1255-62. PubMed ID: 20380510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous Microwave Ablation Versus Robot-Assisted Partial Nephrectomy for Stage I Renal Cell Carcinoma: A Propensity-Matched Cohort Study Focusing Upon Long-Term Follow-Up of Oncologic Outcomes.
    Chlorogiannis DD; Kratiras Z; Efthymiou E; Moulavasilis N; Kelekis N; Chrisofos M; Stravodimos K; Filippiadis DK
    Cardiovasc Intervent Radiol; 2024 May; 47(5):573-582. PubMed ID: 38561521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Clinical Outcomes Following Radiofrequency and Microwave Ablation of Renal Cell Carcinoma at a Single VA Medical Center.
    Abboud SE; Patel T; Soriano S; Giesler J; Alvarado N; Kang P
    Curr Probl Diagn Radiol; 2018; 47(2):98-102. PubMed ID: 28648469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thermal Ablation of Colorectal Lung Metastases: Retrospective Comparison Among Laser-Induced Thermotherapy, Radiofrequency Ablation, and Microwave Ablation.
    Vogl TJ; Eckert R; Naguib NN; Beeres M; Gruber-Rouh T; Nour-Eldin NA
    AJR Am J Roentgenol; 2016 Dec; 207(6):1340-1349. PubMed ID: 27680945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of Microwave Ablation for Small Renal Masses: A Single Center Experience.
    Yong C; Mott SL; Laroia S; Tracy CR
    J Endourol; 2020 Nov; 34(11):1134-1140. PubMed ID: 32611205
    [No Abstract]   [Full Text] [Related]  

  • 30. Microwave treatment of renal cell carcinoma adjacent to renal sinus.
    Gao Y; Liang P; Yu X; Yu J; Cheng Z; Han Z; Duan S; Huang H
    Eur J Radiol; 2016 Nov; 85(11):2083-2089. PubMed ID: 27776662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous microwave ablation of renal cell carcinoma is safe in patients with a solitary kidney.
    Lin Y; Liang P; Yu XL; Yu J; Cheng ZG; Han ZY; Liu FY
    Urology; 2014 Feb; 83(2):357-63. PubMed ID: 24321484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary Outcome of Microwave Ablation of Hepatocellular Carcinoma: Breaking the 3-cm Barrier?
    Thamtorawat S; Hicks RM; Yu J; Siripongsakun S; Lin WC; Raman SS; McWilliams JP; Douek M; Bahrami S; Lu DS
    J Vasc Interv Radiol; 2016 May; 27(5):623-30. PubMed ID: 27013403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
    J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.
    Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S
    J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial experience using microwave ablation therapy for renal tumor treatment: 18-month follow-up.
    Castle SM; Salas N; Leveillee RJ
    Urology; 2011 Apr; 77(4):792-7. PubMed ID: 21324512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Body Mass Index on Perioperative Complications and Oncologic Outcomes in Patients Undergoing Thermal Ablation for Renal Cell Carcinoma.
    Zhou W; Herwald SE; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2021 Jan; 32(1):33-38. PubMed ID: 33308948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Microwave and Radiofrequency Ablation for the Treatment of Small- and Medium-Sized Hepatocellular Carcinomas in a Prospective Randomized Trial.
    Vogl TJ; Martin SS; Gruber-Rouh T; Booz C; Koch V; Nour-Eldin NA; Hussainy Said MN
    Rofo; 2024 May; 196(5):482-490. PubMed ID: 38065541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Safety and Efficacy of Percutaneous Microwave Ablation of Central Versus Peripheral Renal Cell Carcinoma.
    An TJ; Arellano RS
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):281-288. PubMed ID: 33078234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
    Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW
    Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.